Literature DB >> 4714110

Prognosis of Guillain-Barré syndrome in the African: the Nigerian experience.

B O Osuntokun, K Agbebi.   

Abstract

The clinical features of the Guillain-Barré syndrome in 34 Nigerian patients are reported. The patients were treated with oral prednisolone 20 mg three times daily for a minimum of six weeks. Twenty-seven patients recovered completely and five others showed considerable improvement, although three of them appeared to be `steroid dependent'. Two patients died. The good prognosis and the response to treatment with prednisolone in this series is in keeping with an allergic demyelinating neuropathy.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4714110      PMCID： PMC494348          DOI： 10.1136/jnnp.36.3.478

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  28 in total

1.  POLYRADICULONEUROPATHY (GUILLAIN-BARR'E SYNDROME) TREATED WITH 6-MERCAPTOPURINE.

Authors:  K N PALMER
Journal:  Lancet       Date:  1965-04-03       Impact factor: 79.321

2.  SCHWANN-CELL ABNORMALITIES IN DIABETIC NEUROPATHY.

Authors:  P K THOMAS; R G LASCELLES
Journal:  Lancet       Date:  1965-06-26       Impact factor: 79.321

3.  The use of steroids in the treatment of the Guillain-Barre syndrome.

Authors:  G S GRAVESON
Journal:  Proc R Soc Med       Date:  1961-07

4.  Internode length and fibre diameter in developing and regenerating nerves.

Authors:  A D Vizoso; J Z Young
Journal:  J Anat       Date:  1948-04       Impact factor: 2.610

5.  The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria.

Authors:  B O Osuntokun
Journal:  J Neurol Sci       Date:  1971-04       Impact factor: 3.181

6.  Relationship as a clue to causation.

Authors:  B O Osuntokun
Journal:  Lancet       Date:  1971-03-27       Impact factor: 79.321

7.  Autoimmune disease and parasitic infections in Nigerians.

Authors:  B M Greenwood
Journal:  Lancet       Date:  1968-08-17       Impact factor: 79.321

8.  Lymphocyte transformation in the Guillain-Barré syndrome.

Authors:  M Knowles; S Currie; M Saunders; J N Walton; E J Field
Journal:  Lancet       Date:  1969-11-29       Impact factor: 79.321

9.  Experimental allergic neuritis: a radioautographic study.

Authors:  A K Asbury; B G Arnason
Journal:  J Neuropathol Exp Neurol       Date:  1968-10       Impact factor: 3.685

10.  Relapsing corticosteroid-dependent polyneuritis.

Authors:  W B Matthews; D A Howell; R D Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-06       Impact factor: 10.154
View more
  2 in total

Review 1.  Guillain-Barré syndrome in Kenya: a clinical review of 54 patients.

Authors:  M Bahemuka
Journal:  J Neurol       Date:  1988-09       Impact factor: 4.849

2.  [Guillain-Barré syndrome in hospitals in Togo].

Authors:  K Apetse; J J Dongmo Tajeuna; V K Kumako; K P Waklatsi; D Kombate; K Assogba; A K Balogou
Journal:  Med Trop Sante Int       Date:  2021-09-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.